Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | HHV-6 infection management post-HSCT

Per Ljungman • 26 Oct 2019
COSTEM 2019
General Vaccines

Per Ljungman, MD, PhD, Karolinska University Hospital, Solna, Sweden, discusses the management of HHV-6 infection in patients with hematological malignancies after hematopoietic stem cell transplantation (HSCT). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Per Ljungman

Drug-drug interaction management with the novel anti-CMV agents letermovir and maribavir
1:00
Drug-drug interaction management with the novel anti-CMV agents letermovir and maribavir
Per Ljungman • 1 Apr 2025
Does CMV remain a concern when performing transplantation in 2025?
1:00
Does CMV remain a concern when performing transplantation in 2025?
Per Ljungman • 1 Apr 2025
The updated ECIL guidelines for the management of CMV
1:15
The updated ECIL guidelines for the management of CMV
Per Ljungman • 1 Apr 2025
What to expect from TCT 2021?
0:27
What to expect from TCT 2021?
Per Ljungman • 5 Feb 2021

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals